914348-80-4

Basic information

• Product Name: 2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde
• Synonyms: 2-(4-Fluorophenyl)-1,3-thiazole-5-carbaldehyde; 5-thiazolecarboxaldehyde, 2-(4-fluorophenyl)-
• CAS NO: 914348-80-4
• Molecular Formula: C₁₀H₆FNOS
• Molecular Weight: 207.23
• EINECS: 604-604-1
• Mol File: 914348-80-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 346.145°C at 760 mmHg
• Flash Point: 163.143°C
• Appearance: /
• Density: 1.352g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.623
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 0.43±0.10(Predicted)
• CAS DataBase Reference: 2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde(914348-80-4)
• EPA Substance Registry System: 2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde(914348-80-4)

Safety Data

• Hazardous Substances Data: 914348-80-4(Hazardous Substances Data)

Usage

General Description

2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde is a chemical compound with the molecular formula C11H6F3NOS. It is a thiazole-based compound with a substituted phenyl ring containing a trifluoromethyl group and a carbaldehyde functional group. 2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde has potential applications in pharmaceutical research and drug discovery due to its unique structure and potential biological activities. However, further studies are required to fully understand its properties and potential uses.

InChI:InChI=1/C10H6FNOS/c11-8-3-1-7(2-4-8)10-12-5-9(6-13)14-10/h1-6H

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 1005196-13-3 2-(4-fluorophenyl)thiazole 
• 1765-93-1 4-fluoroboronic acid 
• 464192-28-7 2-bromo-1,3-thiazole-5-carbaldehyde 

Downstream Products

• 1429330-22-2 1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethyl acetate 
• 1226001-23-5 1-(2-(4-fluorophenyl)thiazol-5-yl)ethanone 
• 1429330-25-5 1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethanamine 
• 1429330-26-6 N-(1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethyl)acetamide 
• 1429329-63-4 1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethanol 
• 1248685-91-7 1-(2-(4-fluorophenyl)thiazol-5-yl)ethanol 
• 1620546-00-0 C₂₄H₁₂BrClF₂N₂OS 
• 1620546-01-1 C₃₀H₂₄BClF₂N₂O₃S 
• 1620546-02-2 C₃₈H₃₃ClF₂N₆O₄S 
• 1620544-87-7 C₅₂H₅₄F₂N₁₀O₇S 
• 1620545-99-4 C₂₄H₁₄BrClF₂N₂OS 
• 1613081-63-2 C₅₂H₅₄F₂N₁₀O₇S 
• 1620546-02-2 C₃₈H₃₃ClF₂N₆O₄S 

Relevant articles and documents

HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', R 2 R 3, R 4 and R are as defined herein. The present i

PYRIDINE DERIVATIVES

The present application provides novel pyridine compounds and pharmaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. These compounds are useful in inhibiting CYP 17 activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with CPY17 activity. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer, such as prostate cancer.